Title of article :
Viewpoint: The first-line treatment for unresectable hepatocellular carcinoma patients: lenvatinib versus sorafenib, or beyond?
Author/Authors :
xie, feihu chinese academy of medical sciences - peking union medical college hospital - department of liver surgery, Beijing, China , feng, shi chinese academy of medical sciences - peking union medical college hospital - department of liver surgery, Beijing, China , sun, lejia chinese academy of medical sciences - peking union medical college hospital - department of liver surgery, Beijing, China , mao, yilei chinese academy of medical sciences - peking union medical college hospital - department of liver surgery, Beijing, China
From page :
221
To page :
224
Journal title :
Hepatobiliary Surgery an‎d Nutrition
Journal title :
Hepatobiliary Surgery an‎d Nutrition
Record number :
2654465
Link To Document :
بازگشت